Current and Potential Health Claims for Oat Products

Oats: Chemistry and Technology: Second Edition

Volumn , Issue , 2011, Pages 275-300

  Mathews, Rebecca S ^a  

^a R Mathews and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTENTIAL HEALTH;

EID: 84926027471     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-891127-64-9.50018-X     Document Type: Chapter

References (165)

1. AACC (American Association of Cereal Chemists) AACC International defines whole grain http://www.aaccnet.org/definitions/wholegrain.asp.
2. Abrahamson M.J. Optimal glycemic control in type 2 diabetes mellitus: Fasting and postprandial glucose in context. Arch. Intern. Med. 2004, 164:486-491.
3. ADA (American Diabetes Association) Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008, 31:S61-78.
4. AFSSSA (French Food Safety Agency) Food label claims http://www.afssa.fr/index.htm.
5. AFSSA (French Food Safety Agency) Letter of notification to CreaNutrition from AFSSA on the authorization of beta-glucan health claim (French). June 10, 2008 http://www.creanutrition-sof.com/fileadmin/template/creanutrition/files_redakteur/news_internet/AFSSA__AVIS.pdf.
6. Alminger M., Eklund-Jonsson C. Whole-grain cereal products based on a high-fibre barley or oat genotype lower post-prandial glucose and insulin responses in healthy humans. Eur. J. Nutr. 2008, 47:294-300.
7. Aziz A. The glycemic index: Methodological aspects related to the interpretation of health effects and to regulatory labeling. J. AOAC Int. 2009, 92:879-887.
8. Bazzano L.A., Song Y., Bubes V., Good C.K., Manson J.E., Liu S. Dietary intake of whole and refined grain breakfast cereals and weight gain in men. Obes. Res. 2005, 13:1952-1960.
9. Beck E.J., Tosh S.M., Batterham M.J., Tapsell L.C., Huang X.F. Oat beta-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects. Mol. Nutr. Food Res. 2009, 53:1343-1351.
10. Beck E.J., Tapsell L.C., Batterham M.J., Tosh S.M., Huang X.F. Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br. J. Nutr. 2009, 24:1-11.
11. Behall K.M., Scholfield D.J., Hallfrisch J.G. Comparison of glucose and insulin responses to barley and oats. (Abstr.) Diabetes 1999, 48:A463.
12. Behall K.M., Scholfield D.J., Hallfrisch J. Comparison of hormone and glucose responses of overweight women to barley and oats. J. Am. Coll. Nutr. 2005, 24:182-188.
13. Berg A., Konig D., Deibert P., Grathwohl D., Berg A., Baumstark M.W., Franz I.W. Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann. Nutr. Metab. 2003, 47:306-311.
14. Berti C., Riso P., Brusamolino A., Porrini M. Effect on appetite control of minor cereal and pseudocereal products. Br. J. Nutr. 2005, 94:850-858.
15. Biörklund M., van Rees A., Mensink R.P., önning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: A randomised dose-controlled trial. Eur. J. Clin. Nutr. 2005, 59:1272-1281.
16. Biörklund M., Holm J., önning G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann. Nutr. Metab. 2008, 52:83-90.
17. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: Epidemiological perspectives. Int. J. Clin. Pract. Suppl. 2002, 129:5-11.
18. Braaten J.T., Wood P.J., Scott F.W., Riedel K.D., Poste L.M., Collins M.W. Oat gum lowers glucose and insulin after an oral glucose load. Am. J. Clin. Nutr. 1991, 53:1425-1430.
19. Braaten J.T., Scott F.W., Wood P.J., Riedel K.D., Wolynetz M.S., Brule D., Collins M.W. High β-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabetic Med. 1994, 11:312-318.
20. Brand-Miller J., Hayne S., Petocz P., Colagiuri S. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 2003, 26:2261-2267.
21. Brighenti F., Casiraghi M.C., Ciappellano S., Crovetti R., Testolin G. Digestibility of carbohydrates from rice-, oat- and wheat-based ready-to-eat breakfast cereals in children. Eur. J. Clin. Nutr. 1994, 48:617-624.
22. Bryngelsson S., Asp N.-G. Health claims according to Article 13 of the EC Regulation: Suggested priorities with reference to the Swedish Code on health claims and emphasis on relevance. Scand. J. Food Nutr. 2007, 51:127-136.
23. Cara L., Dubois C., Borel P., Armand M., Senft M., Portugal H., Pauli A.M., Bernard P.M., Lairon D. Effects of oat bran, rice bran, wheat fiber, and wheat germ on postprandial lipemia in healthy adults. Am. J. Clin. Nutr. 1992, 55:81-88.
24. Ceriello A., Davidson J., Hanefeld M., Leiter L., Monnier L., Owens D., Tajima N., Tuomilehto J., International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update. Nutr. Metab. Cardiovasc. Dis. 2006, 16:453-456.
25. Codex Alimentarius Commission Draft Guidelines for Use of Nutrition and Health Claims, ALINORM 04/27/22, Appendix III. In: Report of the Thirty-Second Session of the Codex Committee on Food Labeling 2004, Food and Agriculture Organization of the United Nations/World Health Organization, Rome.
26. Davy B.M., Melby C.L., Beske S.D., Ho R.C., Davrath L.R., Davy K.P. Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension. J. Nutr. 2002, 132:394-398.
27. De Moura F.F., Lewis K.D., Falk M.C. Applying the FDA definition of whole grains to the evidence for cardiovascular disease health claims. J. Nutr. 2009, 139:2220S-2226S.
28. de Munter J.S., Hu F.B., Spiegelman D., Franz M., van Dam R.M. Whole grain, bran, and germ intake and risk of type 2 diabetes: A prospective cohort study and systematic review. PLoS. Med. 2007, 4:e261.
29. DGAC (Dietary Guidelines Advisory Committee) Carbohydrates http://www.health.gov/dietaryguidelines/dga2005/report/HTML/D5_Carbs.htm.
30. DHHS/USDA (U.S.Department of Health and Human Services and the U.S.Department of Agriculture) Dietary Guidelines for Americans http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2000/2000DGProfessionalBooklet.pdf.
31. Donahue R.P., Abbott R.D., Reed D.M., Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 1987, 36:689-692.
32. EC (European Commission) Corrigendum to Regulation (EC) No. 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Off. J. Eur. Union L 404, 30 December 2006 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32006R1924R(01):EN:NOT.
33. EC (European Commission) Guidance on the implementation of Regulation No. 1924/2006 on nutrition and health claims made on foods: Conclusions of the Standing Committee on the Food Chain and Animal Health http://ec.europa.eu/food/food/labellingnutrition/claims/guidance:claim_14-12-07.pdf.
34. EFSA (European Food Safety Authority) Scientific opinion on the substantiation of health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No. 1924/2006. EFSA Journal 7:1254. Online http://www.efsa.europa.eu/en/scdocs/doc/nda_op_ej1254_art13%281%29_beta_glucans_related_claims_en,0.pdf.
35. Evira (Food Safety Authority Finland) Report on health claims used in marketing of foodstuffs in Finland http://www.palvelu.fi/evi/files/55_519_492.pdf.
36. FDA (U.S.Food and Drug Administration) Food labeling: Health claims; oats and coronary heart disease. Proposed rule. Fed. Regist. 1996, 61:216-336.
37. FDA (U.S.Food and Drug Administration) Food labeling: Health claims; oats and coronary heart disease. Final rule. Fed. Regist. 1997, 62:3583-3601.
38. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Guidance for industry. Notification of a health claim or nutrient content claim based on an authoritative statement of a scientific body. June 11, 1998 http://www.cfsan.fda.gov/~dms/hclmguid.html.
39. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Health claim notification for whole-grain foods http://www.cfsan.fda.gov/~dms/flgrains.html.
40. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) A Food labeling guide-Appendix C. November 2000 http://www.cfsan.fda.gov/~dms/flg-6c.html.
41. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Food labeling: Health claims; soluble dietary fiber from certain foods and coronary heart disease; interim final rule. Fed. Regist. 2002, 67:61773-61783.
42. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Claims that can be made for conventional foods and dietary supplements. September 2003 http://www.cfsan.fda.gov/~dms/hclaims.html.
43. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Guidance for industry and FDA. Procedures for qualified health claims in the labeling of conventional human food and human dietary supplements http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/foodlabelingnutrition/ucm053832.htm.
44. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Health claim notification for whole-grain foods with moderate fat content. December 9, 2003 http://www.fda.gov/food/labelingnutrition/labelclaims/fdamodernizationactfdamaclaims/ucm073634.htm.
45. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Notification for a health claim based on an authoritative statement: Whole grain products and heart disease. Submitted by Kraft Foods North America, Nov. 25, 2003 http://www.fda.gov/ohrms/dockets/dockets/03q0547/03q-0547-hcn0002-02.pdf.
46. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Guidance for industry: FDA's implementation of qualified health claims: Questions and answers; Final guidance. May 12, 2006 http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/foodlabelingnutrition/ucm053843.htm.
47. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Draft guidance: Whole grain label statements. February 17, 2006 http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/foodlabelingnutrition/ucm059088.htm.
48. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Guidance for industry. Substantiation for dietary supplement claims made under Section 403 (r) (6) of the Federal Food, Drug, and Cosmetic Act. December 2008 http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/dietarysupplements/ucm073200.htm.
49. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Food labeling: Health claims: soluble fiber from certain foods and risk of coronary heart disease. Fed. Regist. 2008, 73:23947-23953.
50. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Guidance for industry: Evidence-based review system for the scientific evaluation of health claims-Final http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/foodlabelingnutrition/ucm073332.htm.
51. FDA (U.S.Food and Drug Administration, Center for Food Safety and Applied Nutrition) Structure/function claims http://www.fda.gov/food/labelingnutrition/labelclaims/structurefunctionclaims/default.htm.
52. Foster-Powell K. International table of glycemic index and glycemic load values. Am. J. Clin. Nutr. 2002, 76:5-56.
53. Frank J., Sundberg B., Kamal-Eldin A., Vessby B., Åman P. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J. Nutr. 2004, 134:1384-1388.
54. Fung T.T., Hu F.B., Pereira M.A., Liu S., Stampfer M.J., Colditz G.A., Willett W.C. Whole-grain intake and the risk of type 2 diabetes: A prospective study in men. Am. J. Clin. Nutr. 2002, 76:535-540.
55. Good C.K., Holschuh N., Albertson A.M., Eldridge A.L. Whole grain consumption and body mass index in adult women: An analysis of NHANES 1999-2000 and the USDA pyramid servings database. J. Am. Coll. Nutr. 2008, 27:80-87.
56. Granfeldt Y., Hagander B., Bjorck I. Metabolic responses to starch in oat and wheat products. On the importance of food structure, incomplete gelatinization or presence of viscous dietary fibre. Eur. J. Clin. Nutr. 1995, 49:189-199.
57. Granfeldt Y., Eliasson A.C., Bjorck I. An examination of the possibility of lowering the glycemic index of oat and barley flakes by minimal processing. J. Nutr. 2000, 130:2207-2214.
58. Granfeldt Y., Nyberg L., Björck I. Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur. J. Clin. Nutr. 2008, 62:600-607.
59. Haffner S.M. Can reducing peaks prevent type 2 diabetes: Implication from recent diabetes prevention trials?. Int. J. Clin. Pract. Suppl. 2002, 129:33-39.
60. Hallfrisch J., Scholfield D.J., Behall K.M. Diets containing soluble oat extracts improve glucose and insulin responses of moderately hypercholesterolemic men and women. Am. J. Clin. Nutr. 1995, 61:379-384.
61. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., Ziegelasch H.J., Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996, 39:1577-1583.
62. He J., Klag M.J., Whelton P.K., Mo J.P., Chen J.Y., Qian M.C., Mo P.S., He G.Q. Oats and buckwheat intake and cardiovascular disease risk factors in an ethnic minority of China. Am. J. Clin. Nutr. 1995, 61:366-372.
63. He J., Streiffer R.H., Muntner P., Krousel-Wood M.A., Whelton P.K. Effect of dietary fiber intake on blood pressure: A randomized, double-blind, placebo-controlled trial. J. Hypertens. 2004, 22:73-80.
64. Heaton K.W., Marcus S.N., Emmett P.M., Bolton C.H. Particle size of wheat, maize, and oat test meals: Effects on plasma glucose and insulin responses and on the rate of starch digestion in vitro. Am. J. Clin. Nutr. 1988, 47:675-682.
65. Hlebowicz J., Wickenberg J., Fahlström R., Björgell O., Almér L.O., Darwiche G. Effect of commercial breakfast fibre cereals compared with corn flakes on postprandial blood glucose, gastric emptying and satiety in healthy subjects: A randomized blinded crossover trial. Nutr. J. 2007, 6(Sept.):22.
66. Hlebowicz J., Darwiche G., Björgell O., Almér L.O. Effect of muesli with 4 g oat beta-glucan on postprandial blood glucose, gastric emptying and satiety in healthy subjects: A randomized crossover trial. J. Am. Coll. Nutr. 2008, 27:470-475.
67. Hodge A.M., English D.R., O'Dea K., Giles G.G. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004, 27:2701-2706.
68. Holm J., Bjorck I. Bioavailability of starch in various wheat-based bread products: Evaluation of metabolic responses in healthy subjects and rate and extent of in vitro starch digestion. Am. J. Clin. Nutr. 1992, 55:420-429.
69. Holm J., Koellreutter B., Wursch P. Influence of sterilization, drying and oat bran enrichment of pasta on glucose and insulin responses in healthy subjects and on the rate and extent of in vitro starch digestion. Eur. J. Clin. Nutr. 1992, 46:629-640.
70. Holt S.H.A., Miller B., Petocz P. A satiety index of common foods. Eur. J. Clin. Nutr. 1995, 49:675-690.
71. IFIC (International Food Information Council) Consumer attitudes toward functional foods/food for health. Executive summary http://www.foodinsight.org/Content/6/IFICExecSumSINGLE_vF2.pdf.
72. Jacobs D.R., Meyer K.A., Kushi L.H. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: The Iowa Women's Health Study. Am. J. Clin. Nutr. 1998, 68:248-257.
73. Jarvis J.K., Pearsall D., Oliner C.M., Schoeller D.A. The effect of food matrix on carbohydrate utilization during moderate exercise. Med. Sci. Sports Exer. 1992, 24:320-326.
74. Jenkins A.L., Jenkins D.J., Zdravkovic U., Wursch P., Vuksan V. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur. J. Clin. Nutr. 2002, 56:622-628.
75. Jenkins D. Starchy foods and glycemic index. Diabetes Care 1988, 11:149-159.
76. Jenkins D.J.A., Wolever T.M.S., Taylor R.H., Barker H., Fielden H., Baldwin J.M., Bowling A.C., Newman H.C., Jenkins A.L., Goff D.V. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34:362-366.
77. Jenkins D.J., Kendall C.W., Augustin L.S., Franceschi S., Hamidi M., Marchie A., Jenkins A.L., Axelsen M. Glycemic index: Overview of implications in health and disease. Am. J. Clin. Nutr. 2002, 76:266S-273S.
78. Jensen M.K., Koh-Banerjee P., Franz M., Sampson L., Gronbaek M., Rimm E.B. Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation. Am. J. Clin. Nutr. 2006, 83:275-283.
79. JHCI (Joint Health Claims Initiative) Generic health claim for wholegrain foods and heart health http://www.jhci.org.uk/approv/wgrainh.htm.
80. JHCI (Joint Health Claims Initiative) Generic health claim for oats and cholesterol http://www.jhci.org.uk/approv/oats.htm.
81. JHCI (Joint Health Claims Initiative) Press release: Joint Health Claims Initiative closing its doors 31/03/07 http://www.jhci.org.uk/press/index.htm.
82. Kabir M., Oppert J.M., Vidal H., Bruzzo F., Fiquet C., Wursch P., Slama G., Rizkalla S.W. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002, 51:819-826.
83. Keenan J.M., Pins J.J., Frazel C., Moran A., Turnquist L. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial. (Abstr.) J. Fam. Pract. 2002, 51:369.
84. Kestin M., Moss R., Clifton P.M., Nestel P.J. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am. J. Clin. Nutr. 1990, 52:661-666.
85. Koh-Banerjee P., Franz M., Sampson L., Liu S., Jacobs D.R., Spiegelman D., Willett W., Rimm E. Changes in whole grain, bran, and cereal fiber consumption in relation to 8-year weight gain among men. Am. J. Clin. Nutr. 2004, 80:1237-1245.
86. Krishnan S., Rosenberg L., Singer M., Hu F.B., Djoussé L., Cupples L.A., Palmer J.R. Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in U.S. black women. Arch. Intern. Med. 2007, 167:2304-2309.
87. Krotkiewski M. Use of fibers in different weight reduction programs. Current Topics in Nutrition and Disease: Dietary Fiber and Obesity 1985, 85-109. Alan R. Liss, Inc., New York.
88. Lau C., Faerch K., Glümer C., Tetens I., Pedersen O., Carstensen B., Jørgensen T., Borch-Johnsen K. Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: The Inter99 Study. Diabetes Care 2005, 28:1397-1403. Erratum in: Diabetes Care 2005 28:2340-2341.
89. Liese A.D., Roach A.K., Sparks K.C., Marquart L., D'Agostino R.B., Mayer-Davis E.J. Whole-grain intake and insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Am. J. Clin. Nutr. 2003, 78:965-971.
90. Liese A.D., Schulz M., Fang F., Wolever T.M., D'Agostino R.B., Sparks K.C., Mayer-Davis E.J. Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study. Diabetes Care 2005, 28:2832-2838.
91. Liljeberg H., Granfeldt Y., Bjorck G.I. Metabolic responses to starch in bread containing intact kernels versus milled flour. Eur. J. Clin. Nutr. 1992, 46:561-575.
92. Liljeberg H.G.M., Granfeldt Y.E., Bjorck I.M.E. Products based on a high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans. J. Nutr. 1996, 126:458-466.
93. Liu S., Manson J., Lee I., Giovannucci E., Rimm E., Manson J.E., Hennekens C.H., Willett W.C. Whole grain consumption and risk of coronary heart disease: Results from the Nurses' Health Study. Am. J. Clin. Nutr. 1999, 70:412-419.
94. Liu S., Manson J.E., Stampfer M.J., Hu F.B., Giovannucci E., Colditz G.A., Hennekens C.H., Willett W.C. A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in U.S. women. Am. J. Public Health 2000, 90:1409-1415.
95. Liu S., Willett W.C., Manson J.E., Hu F.B., Rosner B., Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am. J. Clin. Nutr. 2003, 78:920-927.
96. Livesey G., Taylor R., Hulshof T., Howlett J. Glycemic response and health-A systematic review and meta-analysis: Relations between dietary glycemic properties and health outcomes. Am. J. Clin. Nutr. 2008, 87:258S-268S.
97. Lovegrove J.A., Clohessy A., Milon H., Williams C.M. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am. J. Clin. Nutr. 2000, 72:49-55.
98. Ludwig D.S. The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002, 287:2414-2423.
99. Ludwig D.S., Pereira M.A., Kroenke C.H., Hilner J.E., Van Horn L., Slattery M.L., Jacobs D.R. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999, 282:1539-1546.
100. Lutsey P.L., Jacobs D.R., Kori S., Mayer-Davis E., Shea S., Steffen L.M., Szklo M., Tracy R. Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study. Br. J. Nutr. 2007, 98:397-405.
101. Lyly M., Liukkonen K.H., Salmenkallio-Marttila M., Karhunen L., Poutanen K., Lähteenmäki L. Fibre in beverages can enhance perceived satiety. Eur. J. Nutr. 2009, 48:251-258.
102. Mäkeläinen H., Anttila H., Sihvonen J., Hietanen R.M., Tahvonen R., Salminen E., Mikola M., Sontag-Strohm T. The effect of beta-glucan on the glycemic and insulin index. Eur. J. Clin. Nutr. 2007, 61:779-785.
103. Maki K.C., Davidson M.H., Witchger M.S., Dicklin M.R., Subbaiah P.V. Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men. Int. J. Vitam. Nutr. Res. 2007, 77:347-356.
104. Maki K.C., Galant R., Samuel P., Tesser J., Witchger M.S., Ribaya-Mercado J.D., Blumberg J.B., Geohas J. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur. J. Clin. Nutr. 2007, 61:786-795.
105. Maki K.C., Beiseigel J.M., Jonnalagadda S.S., Gugger C.K., Reeves M.S., Farmer M.V., Kaden V.N., Rains T.M. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J. Am. Diet. Assoc. 2010, 110:205-214.
106. Marquart L. Anatomy of a whole-grain health claim. Pages 27-30 in: Grains for the Health of It: Increasing Grains and Whole-Grain Consumption as a Strategy for Health. (Symp. Proc.) University of Minnesota and the Wheat Foods Council http://www.wheatfoods.org/_FileLibrary/Product/23/grains_for_the_health_of_it.pdf.
107. Marquart L., Wiemer K.L., Jones J.M., Jacob B. Whole grains health claims in the USA and other efforts to increase whole-grain consumption. Proc. Nutr. Soc. 2003, 62:151-160.
108. McCarty M.F. Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Med. Hypotheses 2005, 64:619-627.
109. McKeown N.M., Meigs J.B., Liu S., Wilson P.W., Jacques P.F. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular diseases in the Framingham Offspring Study. Am. J. Clin. Nutr. 2002, 76:390-398.
110. McKeown N.M., Yoshida M., Shea M.K., Jacques P.F., Lichtenstein A.H., Rogers G., Booth S.L., Saltzman E. Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J. Nutr. 2009, 139:1950-1955.
111. Melanson K.J., Angelopoulos T.J., Nguyen V.T., Martini M., Zukley L., Lowndes J., Dube T.J., Fiutem J.J., Yount B.W., Rippe J.M. Consumption of whole-grain cereals during weight loss: Effects on dietary quality, dietary fiber, magnesium, vitamin B-6, and obesity. J. Am. Diet. Assoc. 2006, 106:1380-1388.
112. Meyer K.A., Kushi L.H., Jacobs D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr. 2000, 71:921-930.
113. Miller-Jones J. Glycemic response definitions. Cereal Foods World 2007, 52:54-55.
114. Ministry of Health Malaysia Guide to Nutrition Labelling and Claims http://www.nutriweb.org.my/gallery/Guide%20to%20Nutrition%20Labelling%20and%20Claims.pdf.
115. Mitchell H.L. The glycemic index concept in action. Am. J. Clin. Nutr. 2008, 87:244S-246S.
116. Monro J.A., Shaw M. Glycemic impact, glycemic glucose equivalents, glycemic index, and glycemic load: Definitions, distinctions, and implications. Am. J. Clin. Nutr. 2008, 87:237S-243S.
117. Montonen J., Knekt P., Jarvinen R., Aromaa A., Reunanen A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am. J. Clin. Nutr. 2003, 77:622-629.
118. NCEP (National Cholesterol Education Program) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc (JAMA) 2001, 285:1486-2497.
119. Newby P.K., Maras J., Bakun P., Muller D., Ferrucci L., Tucker K.L. Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease. Am. J. Clin. Nutr. 2007, 86:1745-1753.
120. NFA (National Food Agency, Finland) Guidelines issued on cholesterol claims. Press release 1/15.1.2001 http://www.elintarvikevirasto.fi/english/index.html?page=2566.
121. NFA (National Food Agency, Finland) Guide for the control of health claims http://www.palvelu.fi/evi/files/55_519_269.pdf.
122. NRC (National Research Council, National Academy of Sciences) Diet and Health: Implications for Reducing Chronic Disease Risk 1989, National Academy Press, Washington, DC.
123. Panahi S., Ezatagha A., Temelli F., Vasanthan T., Vuksan V. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. J. Am. Coll. Nutr. 2007, 26:639-644.
124. Paul G. Impact of health claims on industry. Nutr. Today 2001, 36:112-114.
125. Pereira M., Jacobs D., Slatery M., Ruth K., Van Horn L., Hilner J., Kushi L. The association of whole grain intake and fasting insulin in a biracial cohort of young adults: The CARDIA study. CVD Prev. 1998, 1:231-242.
126. Pereira M.A., Jacobs D.R., Pins J.J., Raatz S.K., Gross M.D., Slavin J.L., Seaquist E.R. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am. J. Clin. Nutr. 2002, 75:848-855.
127. Pick M.E., Hawrysh Z.J., Gee M.I., Toth E., Garg M.L., Hardin R.T. Oat bran concentrate bread products improve long-term control of diabetes: A pilot study. J. Am. Diet. Assoc. 1996, 96:1254-1261.
128. Pilch S. Physiological Effects and Health Consequences of Dietary Fiber 1987, Federation of American Biology, Bethesda, MD.
129. Pins J.J., Geleva D., Keenan J.M., Frazel C., O'Connor P.J., Cherney L.M. Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure?. J. Fam. Pract. 2002, 51:353-359.
130. Pi-Sunyer F.X. Glycemic index and disease. Am. J. Clin. Nutr. 2002, 76:290S-298S.
131. Queenan K.M., Stewart M.L., Smith K.N., Thomas W., Fulcher R.G., Slavin J.L. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 2007, 6:6.
132. Reyna-Villasmil N., Bermúdez-Pirela V., Mengual-Moreno E., Arias N., Cano-Ponce C., Leal-Gonzalez E., Souki A., Inglett G.E., Israili Z.H., Hernández-Hernández R., Valasco M., Arraiz N. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am. J. Ther. 2007, 14:203-212.
133. Riccardi G., Rivellese A.A., Giacco R. Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am. J. Clin. Nutr. 2008, 87:269S-274S.
134. Rytter E., Erlanson-Albertsson C., Lindahl L., Lundquist I., Viberg U., Akesson B., Oste R. Changes in plasma insulin, enterostatin, and lipoprotein levels during an energy-restricted dietary regimen including a new oat-based liquid food. Ann. Nutr. Metab. 1996, 40:212-220.
135. Sahyoun N.R., Anderson A.L., Tylavsky F.A., Lee J.S., Sellmeyer D.E., Harris T.B. Dietary glycemic index and glycemic load and the risk of type 2 diabetes in older adults. Am. J. Clin. Nutr. 2008, 87:126-131.
136. Salmeron J., Ascherio A., Rimm E.B., Colditz G.A., Spiegelman D., Jenkins D.J., Stampfer M.J., Wing A.L., Willett W.C. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997, 20:545-550.
137. Salmeron J., Manson J.E., Stampfer M.J., Colditz G.A., Wing A.L., Willett W.C. Dietary fiber, glycemic load, and risk of non-insulin dependent diabetes mellitus in women. JAMA 1997, 277:472-477.
138. Saltzman E., Das S.K., Lichtenstein A.H., Dallal G.E., Corrales A., Schaefer E.J., Greenberg A.S., Roberts S.B. An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J. Nutr. 2001, 131:1465-1470.
139. Schulze M.B., Liu S., Rimm E.D., Manson J.E., Willett W.C., Hu F.B. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am. J. Clin. Nutr. 2004, 80:243-244.
140. Schulze M.B., Schulz M., Heidemann C., Schienkiewitz A., Hoffmann K., Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: A prospective study and meta-analysis. Arch. Intern. Med. 2007, 167:956-965.
141. SNF (Swedish Nutrition Foundation) Statement concerning evaluation of the scientific documentation behind a product specific health claim: Primaliv yoghurt (200g) with müsli (26.5g) http://www.hp-info.nu/prodsp/Finalreport_Primaliv.pdf.
142. SNF (Swedish Nutrition Foundation) Health claims in the labeling and marketing of food products. The food sector's code of practice. Revised version September 2004 http://www.hp-info.nu/SweCode_2004_1.pdf.
143. SNF (Swedish Nutrition Foundation) New generic health claim. (coronary) heart disease-Wholegrain http://www.snf.ideon.se/snf/en/rh/Wholegrain.htm.
144. SNF (Swedish Nutrition Foundation) Article 13.1 list http://www.snf.ideon.se/snf/EGforordning/Art13listan.pdf.
145. Starling S. France approves beta-glucan claim. Food Quality News.com. July 2, 2008 http://www.foodqualitynews.com/content/view/print/52798.
146. Steffen L.M., Jacobs D.R., Murtaugh M.A., Moran A., Steinberger J., Hong C.P., Sinaiko A.R. Whole grain intake is associated with lower body mass and greater insulin sensitivity. Am. J. Epidemiol. 2003, 158:243-250.
147. Stevens J., Burgess M.B., Kaiser D.L., Sheppa C.M. Outpatient management of diabetes mellitus with patient education to increase dietary carbohydrate and fiber. Diabetes Care 1985, 8:359-366.
148. Stevens J., Ahn Juhaeri K., Houston D., Steffan L., Couper D. Dietary fiber intake and glycemic index and incidence of diabetes in African-American and white adults: The ARIC study. Diabetes Care 2002, 25:1715-1721.
149. Swain J.F., Rouse I.L., Curley C.B., Sacks F.M. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N. Engl. J. Med. 1990, 322:147-152.
150. Tapola N., Karvonen H., Niskanen L., Mikola M., Sarkkinen E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr. Metab. Cardiovasc. Dis. 2005, 15:255-261.
151. Tappy L., Gugolz E., Wursch P. Effects of breakfast cereals containing various amounts of β-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 1996, 19:831-834.
152. Temelkova-Kurktschiev T.S., Koehler C., Henkel E., Leonhardt W., Fuecker K., Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000, 23:1830-1834.
153. Ulmius M., Johansson A., önning G. The influence of dietary fibre source and gender on the postprandial glucose and lipid response in healthy subjects. Eur. J. Nutr. 2009, 48:395-402.
154. van de Vijver L.P., Van Den Bosch L.M., Van Den Brandt P.A., Goldbohm R.A. Whole-grain consumption, dietary fibre intake and body mass index in the Netherlands cohort study. Eur. J. Clin. Nutr. 2009, 63:31-38.
155. van den Berg H., van Nieuwland L. Netherlands Code of Practice. Voluntary code for assessing the scientific evidence for health benefits in health claims on food and drink products. In: EFSA Meeting Summary Report: EFSA Conference on Nutrition and Health Claims http://www.efsa.europa.eu/EFSA/Scientific_Document/Efsa_conference:on_nutrition_and_health_claims,0.pdf.
156. Wannamethee S.G., Whincup P.H., Thomas M.C., Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: Potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care 2009, 32:1823-1825.
157. Webster F.H. Whole-grain oats and oat products. Whole-Grain Foods in Health and Disease 2002, 83-123. Am. Assoc. Cereal Chem., St. Paul, MN. L. Marquart, J.L. Slavin, R.G. Fulcher (Eds.).
158. Weickert M.O., Möhlig M., Schöfl C., Arafat A.M., Otto B., Viehoff H., Koebnick C., Kohl A., Spranger J., Pfeiffer A.F. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006, 29:775-780.
159. WHO (World Health Organization) Chronic diseases and their common risk factors http://www.who.int/chp/chronic_disease_report/media/Factsheet1.pdf.
160. WHO (World Health Organization) Solving the chronic disease problem http://www.who.int/chp/chronic_disease_report/media/Factsheet5.pdf.
161. Wolever T.M., Gibbs A.L., Mehling C., Chiasson J.L., Connelly P.W., Josse R.G., Leiter L.A., Maheux P., Rabasa-Lhoret R., Rodger N.W., Ryan E.A. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: No effect on glycated hemoglobin but reduction in C-reactive protein. Am. J. Clin. Nutr. 2008, 87:114-125.
162. Wood P.J., Braaten J.T., Scott F.W., Riedel D., Poste L.M. Comparisons of viscous properties of oat and guar gum and the effects of these and oat bran on glycemic index. J. Agric. Food Chem. 1990, 38:753-757.
163. Wood P.J., Braaten J.T., Scott F.W., Riedel K.D., Wolynetz M.S., Collins M.W. Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br. J. Nutr. 1994, 72:731-743.
164. Wu T., Giovannucci E., Pischon T., Hankinson S.E., Ma J., Rifai N., Rimm E.B. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in U.S. women. Am. J. Clin. Nutr. 2004, 80:1043-1049.
165. Wursch P., Pi-Sunyer F.X. The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care 1997, 20:1775-1778.